Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed3
Terminated1
Other1

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT03511196Early Phase 1Active Not Recruiting
Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer
Adenocarcinoma of the ProstateAdvanced Prostate CancerProstate Cancer+1 more
PrincipalinvestigatorStart date: 2018-09-17
NCT02901548Phase 2Terminated
Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder
Bladder CancerCarcinoma in Situ of Bladder
PrincipalinvestigatorStart date: 2017-02-16
NCT02981797Completed
Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223
Prostate AdenocarcinomaProstate Cancer
PrincipalinvestigatorStart date: 2015-07-22
NCT02415621Early Phase 1Completed
Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer
Prostate Cancer
PrincipalinvestigatorStart date: 2015-04-13
NCT02300610Phase 1Completed
Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
Bladder CancerCarcinoma, Transitional CellRenal Pelvis Cancer+2 more
PrincipalinvestigatorStart date: 2015-02-11

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Prostate CancerProstate AdenocarcinomaStage IV Prostate Cancer+1 more

Worked with same sponsors:

AstraZeneca
Similarity Score11%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Stage IV Prostate CancerAdenocarcinoma of the ProstateProstate Cancer
Similarity Score8%

Primo N. Lara, MD

University of California, Davis

Related
13 trials

Shared therapeutic areas:

Prostate CancerUrinary Bladder CancerCancer of Urethra

Worked with same sponsors:

Bayer
Similarity Score8%

Eric Bellissant, MD, PhD

Rennes University Hospital

Related
26 trials

Shared therapeutic areas:

Prostate AdenocarcinomaProstate Cancer
Similarity Score5%

Chi Fai Ng, MD

Chinese University of Hong Kong

Related
30 trials

Shared therapeutic areas:

Prostate CancerUrinary Bladder Cancer
Similarity Score5%

Kevin Volpp, MD, PhD

University of Pennsylvania

Related
12 trials

Shared therapeutic areas:

Prostate Cancer
Similarity Score3%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Urinary Bladder Cancer
Similarity Score3%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Prostate Cancer
Similarity Score3%

Neha sharma, PhD

Warwick Research Services

Related
11 trials

Shared therapeutic areas:

Prostate Cancer
Similarity Score3%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Urinary Bladder Cancer
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT03511196Early Phase 1PrincipalInvestigator

Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer

Adenocarcinoma of the ProstateAdvanced Prostate CancerProstate Cancer+1 more
Active Not Recruiting
NCT02901548Phase 2PrincipalInvestigator

Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder

Bladder CancerCarcinoma in Situ of Bladder
Terminated
NCT02981797PrincipalInvestigator

Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223

Prostate AdenocarcinomaProstate Cancer
Completed
NCT02415621Early Phase 1PrincipalInvestigator

Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer

Prostate Cancer
Completed
NCT02300610Phase 1PrincipalInvestigator

Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer

Bladder CancerCarcinoma, Transitional CellRenal Pelvis Cancer+2 more
Completed

All 5 trials loaded